Clinical Trial

Study to Assess the Safety and Effectiveness of Beltaven® in Patients With Allergy to Apis Mellifera, Polistes Dominula or Vespula Spp.

Recruiting
View on ClinicalTrials.gov →
Summary
Non-interventional Study to Assess the Safety and Effectiveness Profile of a SCIT Therapy With Beltaven® With Apis mellifera, Polistes dominula or Vespula spp. allergic patients
Trial Details
NCT Number NCT07309822
Lead Sponsor Probelte Pharma S.L.U.
Conditions Allergy
Enrollment 27 participants
Start Date 2025-02-01
Primary Completion 2031-05 (estimated)
Study Completion 2031-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-30